Skip to main content
Clinical Trials/CTRI/2025/05/086449
CTRI/2025/05/086449Not yet recruitingNot Applicable

Treatment of Tinea Corporis (Padarthamarai) with Thipilliver Chooranam A Pilot Study

The Central Council for Research in Siddha1 site in 1 country20 target enrollmentStarted: May 20, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
The primary outcome will be based on the resolution of skin lesions.

Study Overview

Brief Summary

Tinea Corporis also known as ringworm, is a common fungal infection that affects the skin. The fungi causing Tinea Corporis persist on the skin for extended periods, making it challenging to fully eradicate with current treatment and leading to frequent relapses. Thipilliver Chooranam is a powder form of siddha medicine prescribed for ringworm fungal infection.

Study Design

Study Type
Interventional
Allocation
Not Applicable
Masking
Not Applicable

Eligibility Criteria

Ages
18.00 Year(s) to 35.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients who have ringworm infection.

Exclusion Criteria

  • Immunocompromised patients
  • Children, Adolescent Pregnant/ Lactating women
  • Patients who have history of hypersensitivity/ Allergy 4.

Outcomes

Primary Outcomes

The primary outcome will be based on the resolution of skin lesions.

Time Frame: The outcome will be assessed after 4 weeks of intervention

Secondary Outcomes

  • The secondary outcome will be based on the absence of fungi on the skin in the KOH wet mount test.(The outcome will be taken after 4 weeks of treatment.)

Investigators

Sponsor
The Central Council for Research in Siddha
Sponsor Class
Research institution

Study Sites (1)

Loading locations...

Similar Trials